Univec, Inc. (UNVC)
OTCMKTS · Delayed Price · Currency is USD
0.0025
0.00 (0.00%)
Jul 16, 2025, 11:10 AM EDT
Univec Revenue
Univec had revenue of $10.71K in the quarter ending June 30, 2011, with 27.14% growth. This brings the company's revenue in the last twelve months to $28.63K, up 46.77% year-over-year. In the year 2006, Univec had annual revenue of $21.46K, down -73.64%.
Revenue (ttm)
28.63K
Revenue Growth
+46.77%
P/S Ratio
220.29
Revenue / Employee
9.54K
Employees
3
Market Cap
6.31M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2006 | 21.46K | -59.94K | -73.64% |
| Dec 31, 2005 | 81.40K | -246.43K | -75.17% |
| Dec 31, 2004 | 327.83K | -611.92K | -65.12% |
| Dec 31, 2003 | 939.75K | -1.95M | -67.45% |
| Dec 31, 2002 | 2.89M | -1.02M | -26.06% |
| Dec 31, 2001 | Pro | Pro | Pro |
| Dec 31, 2000 | Pro | Pro | Pro |
| Dec 31, 1999 | Pro | Pro | Pro |
| Dec 31, 1998 | Pro | Pro | Pro |
| Dec 31, 1997 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Endo, Inc. | 1.73B |
| Veradigm | 588.02M |
| Tian'an Technology Group | 1.78M |
| Elite Pharmaceuticals | 84.04M |
| Glass House Brands | 215.62M |
| Northwest Biotherapeutics | 1.47M |
| American Oncology Network | 1.76B |
| Silence Therapeutics | 27.70M |
Univec News
- 6 months ago - Univec, Inc. Welcomes Michael Knight to Board of Directors - Accesswire